Thursday, June 13, 2024

SCOTUS’ decision on Mifepristone

 ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

Almost 2 years after the Dobbs decision overturned the federal right to an abortion, the Supreme Court has thrown out a challenge to Mifepristone, the safe and effective drug used in more than half of all abortions nationwide.

While this is a win for women, it may be temporary. As we embrace this victory today, we must be clear-eyed about the anti-choice movement's plans and the steps we need to take so that our rights are not at the mercy of 9 unelected justices.

It's worth noting that the Court did not rule on the merits of the case, known as FDA v. Alliance for Hippocratic Medicine, but rather took a procedural cop out. They ruled that the plaintiffs did not have standing, which means that they are not entitled to pursue the case because they can't show that they were harmed. Another organization—with a better claim to standing—could try the same playbook again and potentially get a different result.

So while this is a setback for the anti-choice agenda, threats to reproductive healthcare remain. In the 2 years since the Dobbs decision, we have seen attacks on several fronts: threats to IVF, extreme state level bans, restrictions on interstate travel to access care, and attacks on life-saving care when women show up to hospitals with a dangerous miscarriage. Republicans have made it very clear where they stand on these issues, and we need to believe them by looking at what they do and not just what they say.

The Court has yet to decide on a case that would force doctors in Idaho and other states to deny life-saving care to women experiencing dangerous miscarriages. Today, Senate Republicans are expected to block a bill to protect IVF nationwide. In the face of these attacks, it's never been more important to have a Senate that's prepared to legislate on the federal right to reproductive care, so that we aren't waiting anxiously every June to see which rights the Supreme Court will take away from us.

It's time to reform the filibuster and codify the Roe standard into federal law and protect access to reproductive healthcare at the federal level. But that won't happen if Republicans flip this seat here in Michigan. Will you chip in $3 to help secure a pro-choice majority in the U.S. Senate and protect choice nationwide?

If you've stored your info with ActBlue, we'll process your contribution instantly:

Thank you,

Elissa


 

PAID FOR BY ELISSA SLOTKIN FOR MICHIGAN

P.O. Box 4145
East Lansing, MI 48826

This email was sent to kmyers209.shamrock5@blogger.com. Email is a very important way we communicate with supporters like you, but if you want to, you can unsubscribe here.

Sign up here to receive fewer emails.

Elissa Slotkin served in the Central Intelligence Agency and the Department of Defense. Use of her job titles and photographs during service do not imply endorsement by the Central Intelligence Agency OR the Department of Defense.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.